Pregnane X receptor as a therapeutic target for cholestatic liver injury

References

• Akimoto T, Hayashi N, Adachi M, Kobayashi N, Zhang XJ, Ohsuga M, Katsuta Y. 2005. Viability and plasma vitamin K levels in the common bile duct-ligated rats. Exp Anim. 54(2):155–161. doi: 10.1538/expanim.54.155.
   PubMed Web of Science ®Google Scholar
• Alabraba E, Nightingale P, Gunson B, Hubscher S, Olliff S, Mirza D, Neuberger J. 2009. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl. 15(3):330–340. doi: 10.1002/lt.21679.
   PubMed Web of Science ®Google Scholar
• Appanna G, Kallis Y. 2020. An update on the management of cholestatic liver diseases. Clin Med. 20(5):513–516. doi: 10.7861/clinmed.2020-0697.
   PubMed Web of Science ®Google Scholar
• Ascenzi P, Bocedi A, Marino M. 2006. Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med. 27(4):299–402. doi: 10.1016/j.mam.2006.07.001.
   PubMedGoogle Scholar
• Baldwin WS. 2019. Phase 0 of the xenobiotic response: nuclear receptors and other transcription factors as a first step in protection from xenobiotics. Nucl Receptor Res. 6:101447. doi: 10.32527/2019/101447.
   PubMedGoogle Scholar
• Bertolini A, Fiorotto R, Strazzabosco M. 2022. Bile acids and their receptors: modulators and therapeutic targets in liver inflammation. Semin Immunopathol. 44(4):547–564. doi: 10.1007/s00281-022-00935-7.
   PubMed Web of Science ®Google Scholar
• Beyer C, Skapenko A, Distler A, Dees C, Reichert H, Munoz L, Leipe J, Schulze-Koops H, Distler O, Schett G, et al. 2013. Activation of pregnane X receptor inhibits experimental dermal fibrosis. Ann Rheum Dis. 72(4):621–625. doi: 10.1136/annrheumdis-2012-202476.
   PubMed Web of Science ®Google Scholar
• Bock KW. 2010. Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels. Biochem Pharmacol. 80(6):771–777. doi: 10.1016/j.bcp.2010.04.034.
   PubMed Web of Science ®Google Scholar
• Bourguet W, Germain P, Gronemeyer H. 2000. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol Sci. 21(10):381–388. doi: 10.1016/s0165-6147(00)01548-0.
   PubMed Web of Science ®Google Scholar
• Cai SY, Boyer JL. 2017. The role of inflammation in the mechanisms of bile acid-induced liver damage. Dig Dis. 35(3):232–234. doi: 10.1159/000450916.
   PubMed Web of Science ®Google Scholar
• Cai X, Young GM, Xie W. 2021. The xenobiotic receptors PXR and CAR in liver physiology, an update. Biochim Biophys Acta Mol Basis Dis. 1867(6):166101. doi: 10.1016/j.bbadis.2021.166101.
   PubMed Web of Science ®Google Scholar
• Carnahan VE, Redinbo MR. 2005. Structure and function of the human nuclear xenobiotic receptor PXR. Curr Drug Metab. 6(4):357–367. doi: 10.2174/1389200054633844.
   PubMed Web of Science ®Google Scholar
• Cemortan M, Sagaidac I, Cernetchi O. 2022. Assessment of vitamin K levels in women with intrahepatic cholestasis of pregnancy. BMC Pregnancy Childbirth. 22(1):534. doi: 10.1186/s12884-022-04875-w.
   PubMed Web of Science ®Google Scholar
• Chai SC, Cherian MT, Wang YM, Chen T. 2016. Small-molecule modulators of PXR and CAR. Biochim Biophys Acta. 1859(9):1141–1154. doi: 10.1016/j.bbagrm.2016.02.013.
   PubMed Web of Science ®Google Scholar
• Chai X, Zeng S, Xie W. 2013. Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond. Expert Opin Drug Metab Toxicol. 9(3):253–266. doi: 10.1517/17425255.2013.754010.
   PubMed Web of Science ®Google Scholar
• Chen WY, Lin SY, Pan HC, Liao SL, Chuang YH, Yen YJ, Lin SY, Chen CJ. 2012. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats. J Nutr Biochem. 23(3):252–264. doi: 10.1016/j.jnutbio.2010.11.022.
   PubMed Web of Science ®Google Scholar
• Cheng J, Shah YM, Gonzalez FJ. 2012. Pregnane X receptor as a target for treatment of inflammatory bowel disorders. Trends Pharmacol Sci. 33(6):323–330. doi: 10.1016/j.tips.2012.03.003.
   PubMed Web of Science ®Google Scholar
• Chiang JY. 2009. Bile acids: regulation of synthesis. J Lipid Res. 50(10):1955–1966. doi: 10.1194/jlr.R900010-JLR200.
   PubMed Web of Science ®Google Scholar
• Chiang JY. 2013. Bile acid metabolism and signaling. Compr Physiol. 3(3):1191–1212. doi: 10.1002/cphy.c120023.
   PubMed Web of Science ®Google Scholar
• Chiang JYL, Ferrell JM. 2018. Bile acid metabolism in liver pathobiology. Gene Expr. 18(2):71–87. doi: 10.3727/105221618X15156018385515.
   PubMedGoogle Scholar
• Congiu M, Mashford ML, Slavin JL, Desmond PV. 2009. Coordinate regulation of metabolic enzymes and transporters by nuclear transcription factors in human liver disease. J Gastroenterol Hepatol. 24(6):1038–1044. doi: 10.1111/j.1440-1746.2009.05800.x.
   PubMed Web of Science ®Google Scholar
• Dawson PA, Karpen SJ. 2015. Intestinal transport and metabolism of bile acids. J Lipid Res. 56(6):1085–1099. doi: 10.1194/jlr.R054114.
   PubMed Web of Science ®Google Scholar
• de Boer JF, Verkade E, Mulder NL, de Vries HD, Huijkman N, Koehorst M, Boer T, Wolters JC, Bloks VW, van de Sluis B, et al. 2020. A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice. J Lipid Res. 61(3):291–305. doi: 10.1194/jlr.RA119000243.
   PubMed Web of Science ®Google Scholar
• Dempsey JL, Wang D, Siginir G, Fei Q, Raftery D, Gu H, Yue Cui J. 2019. Pharmacological activation of PXR and CAR downregulates distinct bile acid-metabolizing intestinal bacteria and alters bile acid homeostasis. Toxicol Sci. 168(1):40–60. doi: 10.1093/toxsci/kfy271.
   PubMed Web of Science ®Google Scholar
• Donepudi AC, Aleksunes LM, Driscoll MV, Seeram NP, Slitt AL. 2012. The traditional ayurvedic medicine, Eugenia jambolana (Jamun fruit), decreases liver inflammation, injury and fibrosis during cholestasis. Liver Int. 32(4):560–573. doi: 10.1111/j.1478-3231.2011.02724.x.
   PubMed Web of Science ®Google Scholar
• Dou JY, Zhang M, Cen H, Chen YQ, Wu YF, Lu F, Zhou J, Liu XS, Gu YY. 2022. Salvia miltiorrhiza Bunge (Danshen) and bioactive compound tanshinone IIA alleviates cisplatin-induced acute kidney injury through regulating PXR/NF-kappaB signaling. Front Pharmacol. 13:860383. doi: 10.3389/fphar.2022.860383.
   PubMed Web of Science ®Google Scholar
• Duttala S, Tobi M, Dingell JD. 2006. Complementary stimulation of hepatobiliary transport and detoxification by rifampicin and ursodeoxycholic acid in humans. Gastroenterology. 130(2):619–620; author reply 620. doi: 10.1053/j.gastro.2006.01.018.
   PubMed Web of Science ®Google Scholar
• Eaton JE, Vuppalanchi R, Reddy R, Sathapathy S, Ali B, Kamath PS. 2020. Liver injury in patients with cholestatic liver disease treated with obeticholic acid. Hepatology. 71(4):1511–1514. doi: 10.1002/hep.31017.
   PubMed Web of Science ®Google Scholar
• Elsharkawy AM, Oakley F, Mann DA. 2005. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis. 10(5):927–939. doi: 10.1007/s10495-005-1055-4.
   PubMed Web of Science ®Google Scholar
• Fan S, Liu C, Jiang Y, Gao Y, Chen Y, Fu K, Yao X, Huang M, Bi H. 2019. Lignans from Schisandra sphenanthera protect against lithocholic acid-induced cholestasis by pregnane X receptor activation in mice. J Ethnopharmacol. 245:112103. doi: 10.1016/j.jep.2019.112103.
   PubMed Web of Science ®Google Scholar
• Fang S, Wang T, Li Y, Xue H, Zou J, Cai J, Shi R, Wu J, Ma Y. 2022. Gardenia jasminoides Ellis polysaccharide ameliorates cholestatic liver injury by alleviating gut microbiota dysbiosis and inhibiting the TLR4/NF-kappaB signaling pathway. Int J Biol Macromol. 205:23–36. doi: 10.1016/j.ijbiomac.2022.02.056.
   PubMed Web of Science ®Google Scholar
• Fery Y, Buschauer I, Salzig C, Lang P, Schrenk D. 2009. Technical pentabromodiphenyl ether and hexabromocyclododecane as activators of the pregnane-X-receptor (PXR). Toxicology. 264(1-2):45–51. doi: 10.1016/j.tox.2009.07.009.
   PubMed Web of Science ®Google Scholar
• Friedman SL. 2008. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 88(1):125–172. doi: 10.1152/physrev.00013.2007.
   PubMed Web of Science ®Google Scholar
• Frissen M, Liao L, Schneider KM, Djudjaj S, Haybaeck J, Wree A, Rolle-Kampczyk U, von Bergen M, Latz E, Boor P, et al. 2021. Bidirectional role of NLRP3 during acute and chronic cholestatic liver injury. Hepatology. 73(5):1836–1854. doi: 10.1002/hep.31494.
   PubMed Web of Science ®Google Scholar
• Goldstein J, Levy C. 2018. Novel and emerging therapies for cholestatic liver diseases. Liver Int. 38(9):1520–1535. doi: 10.1111/liv.13880.
   PubMed Web of Science ®Google Scholar
• Goodwin B, Gauthier KC, Umetani M, Watson MA, Lochansky MI, Collins JL, Leitersdorf E, Mangelsdorf DJ, Kliewer SA, Repa JJ. 2003. Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc Natl Acad Sci USA. 100(1):223–228. doi: 10.1073/pnas.0237082100.
   PubMed Web of Science ®Google Scholar
• Grewal GK, Singh KD, Kanojia N, Rawat C, Kukal S, Jajodia A, Singhal A, Misra R, Nagamani S, Muthusamy K, et al. 2017. Exploring the carbamazepine interaction with human pregnane X receptor and effect on ABCC2 using in vitro and in silico approach. Pharm Res. 34(7):1444–1458. doi: 10.1007/s11095-017-2161-z.
   PubMed Web of Science ®Google Scholar
• Gulamhusein AF, Hirschfield GM. 2020. Primary biliary cholangitis: pathogenesis and therapeutic opportunities. Nat Rev Gastroenterol Hepatol. 17(2):93–110. doi: 10.1038/s41575-019-0226-7.
   PubMed Web of Science ®Google Scholar
• Gwag T, Meng Z, Sui Y, Helsley RN, Park SH, Wang S, Greenberg RN, Zhou C. 2019. Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis. J Hepatol. 70(5):930–940. doi: 10.1016/j.jhep.2018.12.038.
   PubMed Web of Science ®Google Scholar
• Hanada K, Nakai K, Tanaka H, Suzuki F, Kumada H, Ohno Y, Ozawa S, Ogata H. 2012. Effect of nuclear receptor downregulation on hepatic expression of cytochrome P450 and transporters in chronic hepatitis C in association with fibrosis development. Drug Metab Pharmacokinet. 27(3):301–306. doi: 10.2133/dmpk.dmpk-11-rg-077.
   PubMed Web of Science ®Google Scholar
• Haughton EL, Tucker SJ, Marek CJ, Durward E, Leel V, Bascal Z, Monaghan T, Koruth M, Collie-Duguid E, Mann DA, et al. 2006. Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro. Gastroenterology. 131(1):194–209. doi: 10.1053/j.gastro.2006.04.012.
   PubMed Web of Science ®Google Scholar
• He J, Nishida S, Xu M, Makishima M, Xie W. 2011. PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts. Gastroenterology. 140(7):2095–2106. doi: 10.1053/j.gastro.2011.02.055.
   PubMed Web of Science ®Google Scholar
• Helgadottir H, Folvik G, Vesterhus M. 2023. Improvement of cholestatic episodes in patients with benign recurrent intrahepatic cholestasis (BRIC) treated with rifampicin. A long-term follow-up. Scand J Gastroenterol. 58(5):512–520. doi: 10.1080/00365521.2022.2143725.
   PubMed Web of Science ®Google Scholar
• Hirschfield GM, Heathcote EJ, Gershwin ME. 2010. Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology. 139(5):1481–1496. doi: 10.1053/j.gastro.2010.09.004.
   PubMed Web of Science ®Google Scholar
• Hofmann AF. 2009. The enterohepatic circulation of bile acids in mammals: form and functions. Front Biosci (Landmark Ed). 14(7):2584–2598. doi: 10.2741/3399.
   PubMedGoogle Scholar
• Hogle BC, Guan X, Folan MM, Xie W. 2018. PXR as a mediator of herb-drug interaction. J Food Drug Anal. 26(2S):S26–S31. doi: 10.1016/j.jfda.2017.11.007.
   PubMedGoogle Scholar
• Horie-Inoue K, Inoue S. 2008. Steroid and xenobiotic receptor mediates a novel vitamin K2 signaling pathway in osteoblastic cells. J Bone Miner Metab. 26(1):9–12. doi: 10.1007/s00774-007-0792-6.
   PubMed Web of Science ®Google Scholar
• Huang P, Chandra V, Rastinejad F. 2010. Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annu Rev Physiol. 72:247–272. doi: 10.1146/annurev-physiol-021909-135917.
   PubMed Web of Science ®Google Scholar
• Huang D, Zhao YY, Wang RM, Li W, Yuan FY, Yan XL, Yang X, Tang GH, Yin S, Bi HC. 2022. Natural product-based screening led to the discovery of a novel PXR agonist with anti-cholestasis activity. Acta Pharmacol Sin. 43(8):2139–2146. doi: 10.1038/s41401-021-00793-3.
   PubMed Web of Science ®Google Scholar
• Ihunnah CA, Jiang M, Xie W. 2011. Nuclear receptor PXR, transcriptional circuits and metabolic relevance. Biochim Biophys Acta. 1812(8):956–963. doi: 10.1016/j.bbadis.2011.01.014.
   PubMed Web of Science ®Google Scholar
• Isbrucker RA, Burdock GA. 2006. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol. 46(3):167–192. doi: 10.1016/j.yrtph.2006.06.002.
   PubMed Web of Science ®Google Scholar
• Jarocki P, Podleśny M, Glibowski P, Targoński Z. 2014. A new insight into the physiological role of bile salt hydrolase among intestinal bacteria from the genus Bifidobacterium. PLoS One. 9(12):e114379. doi: 10.1371/journal.pone.0114379.
   PubMed Web of Science ®Google Scholar
• Jia W, Wei M, Rajani C, Zheng X. 2021. Targeting the alternative bile acid synthetic pathway for metabolic diseases. Protein Cell. 12(5):411–425. doi: 10.1007/s13238-020-00804-9.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhou Y, Song S, Fan S, Gao Y, Li Y, Huang M, Bi H. 2022. St. John’s Wort exacerbates acetaminophen-induced liver injury by activation of PXR and CYP-mediated bioactivation. Toxicol Sci. 190(1):54–63. doi: 10.1093/toxsci/kfac094.
   PubMed Web of Science ®Google Scholar
• Jiao T, Yao X, Zhao Y, Zhou Y, Gao Y, Fan S, Chen P, Li X, Jiang Y, Yang X, et al. 2020. Dexamethasone-induced liver enlargement is related to PXR/YAP activation and lipid accumulation but not hepatocyte proliferation. Drug Metab Dispos. 48(9):830–839. doi: 10.1124/dmd.120.000061.
   PubMed Web of Science ®Google Scholar
• Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD, Tomkinson NC, LeCluyse EL, Lambert MH, Willson TM, et al. 2000. The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol Endocrinol. 14(1):27–39. doi: 10.1210/mend.14.1.0409.
   PubMed Web of Science ®Google Scholar
• Jonker JW, Liddle C, Downes M. 2012. FXR and PXR: potential therapeutic targets in cholestasis. J Steroid Biochem Mol Biol. 130(3-5):147–158. doi: 10.1016/j.jsbmb.2011.06.012.
   PubMed Web of Science ®Google Scholar
• Juřica J, Dovrtělová G, Nosková K, Zendulka O. 2016. Bile acids, nuclear receptors and cytochrome P450. Physiol Res. 65(Suppl 4):S427–S440. doi: 10.33549/physiolres.933512.
   PubMedGoogle Scholar
• Kamaraj R, Drastik M, Maixnerova J, Pavek P. 2022. Allosteric antagonism of the pregnane X receptor (PXR): current-state-of-the-art and prediction of novel allosteric sites. Cells. 11(19):2974. doi: 10.3390/cells11192974.
   PubMed Web of Science ®Google Scholar
• Karpen SJ, Trauner M. 2010. The new therapeutic frontier–nuclear receptors and the liver. J Hepatol. 52(3):455–462. doi: 10.1016/j.jhep.2009.12.002.
   PubMed Web of Science ®Google Scholar
• Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, Tontonoz P, Kliewer S, Willson TM, Edwards PA. 2002. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem. 277(4):2908–2915. doi: 10.1074/jbc.M109326200.
   PubMed Web of Science ®Google Scholar
• Kawana K, Ikuta T, Kobayashi Y, Gotoh O, Takeda K, Kawajiri K. 2003. Molecular mechanism of nuclear translocation of an orphan nuclear receptor, SXR. Mol Pharmacol. 63(3):524–531. doi: 10.1124/mol.63.3.524.
   PubMed Web of Science ®Google Scholar
• Kim SW, Md H, Cho M, Kim NH, Choi HY, Han JW, Park HJ, Oh JW, Shin JG. 2017. Role of 14-3-3 sigma in over-expression of P-gp by rifampin and paclitaxel stimulation through interaction with PXR.Cell Signal. 31:124–134. doi: 10.1016/j.cellsig.2017.01.001.
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Goodwin B, Willson TM. 2002. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev. 23(5):687–702. doi: 10.1210/er.2001-0038.
   PubMed Web of Science ®Google Scholar
• Kojima H, Sata F, Takeuchi S, Sueyoshi T, Nagai T. 2011. Comparative study of human and mouse pregnane X receptor agonistic activity in 200 pesticides using in vitro reporter gene assays. Toxicology. 280(3):77–87. doi: 10.1016/j.tox.2010.11.008.
   PubMed Web of Science ®Google Scholar
• Kullak-Ublick GA, Becker MB. 2003. Regulation of drug and bile salt transporters in liver and intestine. Drug Metab Rev. 35(4):305–317. doi: 10.1081/dmr-120026398.
   PubMed Web of Science ®Google Scholar
• Kurzawski M, Dziedziejko V, Post M, Wójcicki M, Urasińska E, Miętkiewski J, Droździk M. 2012. Expression of genes involved in xenobiotic metabolism and transport in end-stage liver disease: up-regulation of ABCC4 and CYP1B1. Pharmacol Rep. 64(4):927–939. doi: 10.1016/s1734-1140(12)70888-5.
   PubMed Web of Science ®Google Scholar
• Kwong EK, Zhou H. 2019. Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseases. Liver Res. 3(1):19–24. doi: 10.1016/j.livres.2019.02.003.
   PubMedGoogle Scholar
• Landes N, Birringer M, Brigelius-Flohé R. 2003. Homologous metabolic and gene activating routes for vitamins E and K. Mol Aspects Med. 24(6):337–344. doi: 10.1016/s0098-2997(03)00029-3.
   PubMed Web of Science ®Google Scholar
• Lawrence T. 2009. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 1(6):a001651. doi: 10.1101/cshperspect.a001651.
   PubMed Web of Science ®Google Scholar
• Lazar MA. 2003. Nuclear receptor corepressors. Nucl Recept Signal. 1:e001. doi: 10.1621/nrs.01001.
   PubMedGoogle Scholar
• Liang H, Yang X, Li H, Wang X, Su H, Li X, Tian J, Cai C, Huang M, Bi H. 2023. Schisandrol B protects against cholestatic liver injury by inhibiting pyroptosis through pregnane X receptor. Biochem Pharmacol. 211:115526. doi: 10.1016/j.bcp.2022.115222.
   PubMed Web of Science ®Google Scholar
• Lickteig AJ, Slitt AL, Arkan MC, Karin M, Cherrington NJ. 2007. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. Drug Metab Dispos. 35(3):402–409. doi: 10.1124/dmd.106.012138.
   PubMed Web of Science ®Google Scholar
• Lille-Langoy R, Karlsen OA, Myklebust LM, Goldstone JV, Mork-Jansson A, Male R, Blumberg B, Stegeman JJ, Goksoyr A. 2019. Sequence variations in pxr (nr1i2) from zebrafish (Danio rerio) strains affect nuclear receptor function. Toxicol Sci. 168(1):28–39. doi: 10.1093/toxsci/kfy269.
   PubMed Web of Science ®Google Scholar
• Lin W, Wang YM, Chai SC, Lv L, Zheng J, Wu J, Zhang Q, Wang YD, Griffin PR, Chen T. 2017. SPA70 is a potent antagonist of human pregnane X receptor. Nat Commun. 8(1):741. doi: 10.1038/s41467-017-00780-5.
   PubMed Web of Science ®Google Scholar
• Liu T, Beck JP, Hao J. 2022a. A concise review on hPXR ligand-recognizing residues and structure-based strategies to alleviate hPXR transactivation risk. RSC Med Chem. 13(2):129–137. doi: 10.1039/d1md00348h.
   PubMedGoogle Scholar
• Liu P, Jiang L, Kong W, Xie Q, Li P, Liu X, Zhang J, Liu M, Wang Z, Zhu L, et al. 2022b. PXR activation impairs hepatic glucose metabolism partly via inhibiting the HNF4alpha-GLUT2 pathway. Acta Pharm Sin B. 12(5):2391–2405. doi: 10.1016/j.apsb.2021.09.031.
   PubMed Web of Science ®Google Scholar
• Lv C, Huang L. 2020. Xenobiotic receptors in mediating the effect of sepsis on drug metabolism. Acta Pharm Sin B. 10(1):33–41. doi: 10.1016/j.apsb.2019.12.003.
   PubMed Web of Science ®Google Scholar
• Lv Y, Luo Y-Y, Ren H-W, Li C-J, Xiang Z-X, Luan Z-L. 2022. The role of pregnane X receptor (PXR) in substance metabolism. Front Endocrinol (Lausanne). 13:959902. doi: 10.3389/fendo.2022.959902.
   PubMed Web of Science ®Google Scholar
• Ly JQ, Messick K, Qin A, Takahashi RH, Choo EF. 2017. Utility of CYP3A4 and PXR-CAR-CYP3A4/3A7 transgenic mouse models to assess the magnitude of CYP3A4 mediated drug-drug interactions. Mol Pharm. 14(5):1754–1759. doi: 10.1021/acs.molpharmaceut.7b00006.
   PubMedGoogle Scholar
• Lynch C, Sakamuru S, Huang R, Niebler J, Ferguson SS, Xia M. 2021. Characterization of human pregnane X receptor activators identified from a screening of the Tox21 compound library. Biochem Pharmacol. 184:114368. doi: 10.1016/j.bcp.2020.114368.
   PubMed Web of Science ®Google Scholar
• Ma X, Idle JR, Gonzalez FJ. 2008. The pregnane X receptor: from bench to bedside. Expert Opin Drug Metab Toxicol. 4(7):895–908. doi: 10.1517/17425255.4.7.895.
   PubMed Web of Science ®Google Scholar
• Maillette de Buy Wenniger L, Beuers U. 2010. Bile salts and cholestasis. Dig Liver Dis. 42(6):409–418. doi: 10.1016/j.dld.2010.03.015.
   PubMedGoogle Scholar
• Manda VK, Avula B, Dale OR, Ali Z, Khan IA, Walker LA, Khan SI. 2017. PXR mediated induction of CYP3A4, CYP1A2, and P-gp by Mitragyna speciosa and its alkaloids. Phytother Res. 31(12):1935–1945. doi: 10.1002/ptr.5942.
   PubMed Web of Science ®Google Scholar
• Marschall HU, Wagner M, Zollner G, Fickert P, Diczfalusy U, Gumhold J, Silbert D, Fuchsbichler A, Benthin L, Grundstrom R, et al. 2005. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology. 129(2):476–485. doi: 10.1016/j.gastro.2005.05.009.
   PubMed Web of Science ®Google Scholar
• Mbatchi LC, Robert J, Ychou M, Boyer JC, Del Rio M, Gassiot M, Thomas F, Tubiana N, Evrard A. 2016. Effect of single nucleotide polymorphisms in the xenobiotic-sensing receptors NR1I2 and NR1I3 on the pharmacokinetics and toxicity of irinotecan in colorectal cancer patients. Clin Pharmacokinet. 55(9):1145–1157. doi: 10.1007/s40262-016-0392-5.
   PubMed Web of Science ®Google Scholar
• McGlone ER, Bloom SR. 2019. Bile acids and the metabolic syndrome. Ann Clin Biochem. 56(3):326–337. doi: 10.1177/0004563218817798.
   PubMed Web of Science ®Google Scholar
• Mnif W, Pascussi JM, Pillon A, Escande A, Bartegi A, Nicolas JC, Cavaillès V, Duchesne MJ, Balaguer P. 2007. Estrogens and antiestrogens activate hPXR. Toxicol Lett. 170(1):19–29. doi: 10.1016/j.toxlet.2006.11.016.
   PubMed Web of Science ®Google Scholar
• Mohandas S, Vairappan B. 2020. Pregnane X receptor activation by its natural ligand Ginkgolide-A improves tight junction proteins expression and attenuates bacterial translocation in cirrhosis. Chem Biol Interact. 315:108891. doi: 10.1016/j.cbi.2019.108891.
   PubMed Web of Science ®Google Scholar
• Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, Kliewer SA. 2000. St. John’s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci U S A. 97(13):7500–7502. doi: 10.1073/pnas.130155097.
   PubMed Web of Science ®Google Scholar
• Moore DD, Kato S, Xie W, Mangelsdorf DJ, Schmidt DR, Xiao R, Kliewer SA. 2006. International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor. Pharmacol Rev. 58(4):742–759. doi: 10.1124/pr.58.4.6.
   PubMed Web of Science ®Google Scholar
• Motta S, Callea L, Giani Tagliabue S, Bonati L. 2018. Exploring the PXR ligand binding mechanism with advanced molecular dynamics methods. Sci Rep. 8(1):16207. doi: 10.1038/s41598-018-34373-z.
   PubMedGoogle Scholar
• Mulder TAM, van Eerden RAG, de With M, Elens L, Hesselink DA, Matic M, Bins S, Mathijssen RHJ, van Schaik RHN. 2021. CYP3A4 (*)22 genotyping in clinical practice: ready for implementation? Front Genet. 12:711943. doi: 10.3389/fgene.2021.711943.
   PubMed Web of Science ®Google Scholar
• Mu Y, Zhang J, Zhang S, Zhou HH, Toma D, Ren S, Huang L, Yaramus M, Baum A, Venkataramanan R, et al. 2006. Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. J Pharmacol Exp Ther. 316(3):1369–1377. doi: 10.1124/jpet.105.094342.
   PubMed Web of Science ®Google Scholar
• Mu M, Zuo S, Wu RM, Deng KS, Lu S, Zhu JJ, Zou GL, Yang J, Cheng ML, Zhao XK. 2018. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-beta/Smad signaling pathway. Drug Des Devel Ther. 12:4107–4115. doi: 10.2147/DDDT.S186726.
   PubMed Web of Science ®Google Scholar
• Naito H, Jia X, Yetti H, Yanagiba Y, Tamada H, Kitamori K, Hayashi Y, Wang D, Kato M, Ishii A, et al. 2016. Importance of detoxifying enzymes in differentiating fibrotic development between SHRSP5/Dmcr and SHRSP rats. Environ Health Prev Med. 21(5):368–381. doi: 10.1007/s12199-016-0539-x.
   PubMed Web of Science ®Google Scholar
• Okamura M, Shizu R, Abe T, Kodama S, Hosaka T, Sasaki T, Yoshinari K. 2020. PXR functionally interacts with NF-κB and AP-1 to downregulate the inflammation-induced expression of chemokine CXCL2 in Mice. Cells. 9(10):E2296. doi: 10.3390/cells9102296.
   PubMed Web of Science ®Google Scholar
• Oladimeji PO, Chen T. 2018. PXR: more than just a master xenobiotic receptor. Mol Pharmacol. 93(2):119–127. doi: 10.1124/mol.117.110155.
   PubMedGoogle Scholar
• Onji M, Fujioka S, Takeuchi Y, Takaki T, Osawa T, Yamamoto K, Itoshima T. 2009. Clinical characteristics of drug-induced liver injury in the elderly. Hepatol Res. 39(6):546–552. doi: 10.1111/j.1872-034X.2009.00492.x.
   PubMed Web of Science ®Google Scholar
• Orozco-Aguilar J, Simon F, Cabello-Verrugio C. 2021. Redox-dependent effects in the physiopathological role of bile acids. Oxid Med Cell Longev. 2021:4847941. doi: 10.1155/2021/4847941.
   PubMed Web of Science ®Google Scholar
• Pandak WM, Kakiyama G. 2019. The acidic pathway of bile acid synthesis: not just an alternative pathway(⋆). Liver Res. 3(2):88–98. doi: 10.1016/j.livres.2019.05.001.
   PubMedGoogle Scholar
• Panossian A, Wikman G. 2008. Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. J Ethnopharmacol. 118(2):183–212. doi: 10.1016/j.jep.2008.04.020.
   PubMed Web of Science ®Google Scholar
• Pavek P. 2016. Pregnane X receptor (PXR)-mediated gene repression and cross-talk of PXR with other nuclear receptors via coactivator interactions. Front Pharmacol. 7:456. doi: 10.3389/fphar.2016.00456.
   PubMed Web of Science ®Google Scholar
• Poudel S, Huber AD, Chen T. 2023. Regulation of nuclear receptors PXR and CAR by small molecules and signal crosstalk: roles in drug metabolism and beyond. Drug Metab Dispos. 51(2):228–236. doi: 10.1124/dmd.122.000858.
   PubMed Web of Science ®Google Scholar
• Rashidian A, Mustonen EK, Kronenberger T, Schwab M, Burk O, Laufer SA, Pantsar T. 2022. Discrepancy in interactions and conformational dynamics of pregnane X receptor (PXR) bound to an agonist and a novel competitive antagonist. Comput Struct Biotechnol J. 20:3004–3018. doi: 10.1016/j.csbj.2022.06.020.
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Kang DJ, Hylemon PB. 2006. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 47(2):241–259. doi: 10.1194/jlr.R500013-JLR200.
   PubMed Web of Science ®Google Scholar
• Rosenfeld MG, Lunyak VV, Glass CK. 2006. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20(11):1405–1428. doi: 10.1101/gad.1424806.
   PubMed Web of Science ®Google Scholar
• Samant H, Manatsathit W, Dies D, Shokouh-Amiri H, Zibari G, Boktor M, Alexander JS. 2019. Cholestatic liver diseases: an era of emerging therapies. World J Clin Cases. 7(13):1571–1581. doi: 10.12998/wjcc.v7.i13.1571.
   PubMed Web of Science ®Google Scholar
• Sarker M, Getrajdman C, Warren L, Ferrara L. 2022. Severe fat-soluble vitamin deficiency suspected secondary to intrahepatic cholestasis of pregnancy: a case report. Case Rep Womens Health. 35:e00430. doi: 10.1016/j.crwh.2022.e00430.
   PubMedGoogle Scholar
• Sayaf K, Zanotto I, Russo FP, Gabbia D, De Martin S. 2021. The nuclear receptor PXR in chronic liver disease. Cells. 11(1):61. doi: 10.3390/cells11010061.
   PubMed Web of Science ®Google Scholar
• Şehirli AÖ, Kökeş A, Velioğlu-Öğünç A, Tetik Ş, Özkan N, Çetinel Ş, Sayıner S, Dülger G. 2021. The effects of spironolactone in preventing bile duct ligation-induced hepatitis in a rat model. Iran J Pharm Res. 20(2):35–44. doi: 10.22037/ijpr.2020.112488.13786.
   PubMed Web of Science ®Google Scholar
• Shao YY, Guo Y, Feng XJ, Liu JJ, Chang ZP, Deng GF, Xu D, Gao JP, Hou RG. 2021. Oridonin attenuates TNBS-induced post-inflammatory irritable bowel syndrome via PXR/NF-kappaB signaling. Inflammation. 44(2):645–658. doi: 10.1007/s10753-020-01364-0.
   PubMed Web of Science ®Google Scholar
• Shin DJ, Wang L. 2019. Bile acid-activated receptors: a review on FXR and other nuclear receptors. Handb Exp Pharmacol. 256:51–72. doi: 10.1007/164_2019_236.
   PubMedGoogle Scholar
• Sinz MW. 2013. Evaluation of pregnane X receptor (PXR)-mediated CYP3A4 drug-drug interactions in drug development. Drug Metab Rev. 45(1):3–14. doi: 10.3109/03602532.2012.743560.
   PubMed Web of Science ®Google Scholar
• Song Y, Tran M, Wang L, Shin DJ, Wu J. 2022. MiR-200c-3p targets SESN1 and represses the IL-6/AKT loop to prevent cholangiocyte activation and cholestatic liver fibrosis. Lab Invest. 102(5):485–493. doi: 10.1038/s41374-021-00710-6.
   PubMed Web of Science ®Google Scholar
• Staudinger JL, Ding X, Lichti K. 2006. Pregnane X receptor and natural products: beyond drug-drug interactions. Expert Opin Drug Metab Toxicol. 2(6):847–857. doi: 10.1517/17425255.2.6.847.
   PubMed Web of Science ®Google Scholar
• Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, Liu Y, Klaassen CD, Brown KK, Reinhard J, et al. 2001. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A. 98(6):3369–3374. doi: 10.1073/pnas.051551698.
   PubMed Web of Science ®Google Scholar
• Staudinger J, Liu Y, Madan A, Habeebu S, Klaassen CD. 2001. Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos. 29(11):1467–1472.
   PubMed Web of Science ®Google Scholar
• Stedman CA, Liddle C, Coulter SA, Sonoda J, Alvarez JG, Moore DD, Evans RM, Downes M. 2005. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Proc Natl Acad Sci U S A. 102(6):2063–2068. doi: 10.1073/pnas.0409794102.
   PubMed Web of Science ®Google Scholar
• Sultana H, Komai M, Shirakawa H. 2021. The role of vitamin K in cholestatic liver disease. Nutrients. 13(8):2515. doi: 10.3390/nu13082515.
   PubMed Web of Science ®Google Scholar
• Sultana H, Watanabe K, Rana MM, Takashima R, Ohashi A, Komai M, Shirakawa H. 2018. Effects of vitamin K(2) on the expression of genes involved in bile acid synthesis and glucose homeostasis in mice with humanized PXR. Nutrients. 10(8):982. doi: 10.3390/nu10080982.
   PubMed Web of Science ®Google Scholar
• Sun L, Sun Z, Wang Q, Zhang Y, Jia Z. 2022. Role of nuclear receptor PXR in immune cells and inflammatory diseases. Front Immunol. 13:969399. doi: 10.3389/fimmu.2022.969399.
   PubMed Web of Science ®Google Scholar
• Svegliati-Baroni G, Ridolfi F, Hannivoort R, Saccomanno S, Homan M, De Minicis S, Jansen PL, Candelaresi C, Benedetti A, Moshage H. 2005. Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor. Gastroenterology. 128(4):1042–1055. doi: 10.1053/j.gastro.2005.01.007.
   PubMed Web of Science ®Google Scholar
• Tebbens JD, Azar M, Friedmann E, Lanzendorfer M, Pavek P. 2018. Mathematical models in the description of pregnane X receptor (PXR)-regulated cytochrome P450 enzyme induction. Int J Mol Sci. 19(6):1785. doi: 10.3390/ijms19061785.
   PubMed Web of Science ®Google Scholar
• Teng S, Piquette-Miller M. 2005. The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice. J Pharmacol Exp Ther. 312(2):841–848. doi: 10.1124/jpet.104.076141.
   PubMed Web of Science ®Google Scholar
• Teng S, Piquette-Miller M. 2007. Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis. Br J Pharmacol. 151(3):367–376. doi: 10.1038/sj.bjp.0707235.
   PubMed Web of Science ®Google Scholar
• Virani S, Akers A, Stephenson K, Smith S, Kennedy L, Alpini G, Francis H. 2018. Comprehensive review of molecular mechanisms during cholestatic liver injury and cholangiocarcinoma. J Liver. 7(3):231. doi: 10.4172/2167-0889.1000231.
   PubMedGoogle Scholar
• Wagner M, Halilbasic E, Marschall HU, Zollner G, Fickert P, Langner C, Zatloukal K, Denk H, Trauner M. 2005. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology. 42(2):420–430. doi: 10.1002/hep.20784.
   PubMed Web of Science ®Google Scholar
• Wallace K, Cowie DE, Konstantinou DK, Hill SJ, Tjelle TE, Axon A, Koruth M, White SA, Carlsen H, Mann DA, et al. 2010. The PXR is a drug target for chronic inflammatory liver disease. J Steroid Biochem Mol Biol. 120(2-3):137–148. doi: 10.1016/j.jsbmb.2010.04.012.
   PubMed Web of Science ®Google Scholar
• Wang YM, Chai SC, Brewer CT, Chen T. 2014. Pregnane X receptor and drug-induced liver injury. Expert Opin Drug Metab Toxicol. 10(11):1521–1532. doi: 10.1517/17425255.2014.963555.
   PubMed Web of Science ®Google Scholar
• Wang YM, Lin W, Chai SC, Wu J, Ong SS, Schuetz EG, Chen T. 2013. Piperine activates human pregnane X receptor to induce the expression of cytochrome P450 3A4 and multidrug resistance protein 1. Toxicol Appl Pharmacol. 272(1):96–107. doi: 10.1016/j.taap.2013.05.014.
   PubMed Web of Science ®Google Scholar
• Wang Q, Song GC, Weng FY, Zou B, Jin JY, Yan DM, Tan B, Zhao J, Li Y, Qiu FR. 2022. Hepatoprotective effects of glycyrrhetinic acid on lithocholic acid-induced cholestatic liver injury through choleretic and anti-inflammatory mechanisms. Front Pharmacol. 13:881231. doi: 10.3389/fphar.2022.881231.
   PubMed Web of Science ®Google Scholar
• Wang YG, Zhou JM, Ma ZC, Li H, Liang QD, Tan HL, Xiao CR, Zhang BL, Gao Y. 2012. Pregnane X receptor mediated-transcription regulation of CYP3A by glycyrrhizin: a possible mechanism for its hepatoprotective property against lithocholic acid-induced injury. Chem Biol Interact. 200(1):11–20. doi: 10.1016/j.cbi.2012.08.023.
   PubMed Web of Science ®Google Scholar
• Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, Willson TM, Kliewer SA, Redinbo MR. 2001. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science. 292(5525):2329–2333. doi: 10.1126/science.1060762.
   PubMed Web of Science ®Google Scholar
• Willson TM, Kliewer SA. 2002. PXR, CAR and drug metabolism. Nat Rev Drug Discov. 1(4):259–266. doi: 10.1038/nrd753.
   PubMed Web of Science ®Google Scholar
• Woolbright BL, Antoine DJ, Jenkins RE, Bajt ML, Park BK, Jaeschke H. 2013. Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice. Toxicol Appl Pharmacol. 273(3):524–531. doi: 10.1016/j.taap.2013.09.023.
   PubMed Web of Science ®Google Scholar
• Wright MC. 2006. The impact of pregnane X receptor activation on liver fibrosis. Biochem Soc Trans. 34(Pt 6):1119–1123. doi: 10.1042/bst0341119.
   PubMedGoogle Scholar
• Wu B, Li S, Dong D. 2013. 3D structures and ligand specificities of nuclear xenobiotic receptors CAR, PXR and VDR. Drug Discov Today. 18(11-12):574–581. doi: 10.1016/j.drudis.2013.01.001.
   PubMed Web of Science ®Google Scholar
• Xie W, Yeuh MF, Radominska-Pandya A, Saini SP, Negishi Y, Bottroff BS, Cabrera GY, Tukey RH, Evans RM. 2003. Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Natl Acad Sci USA. 100(7):4150–4155. doi: 10.1073/pnas.0438010100.
   PubMed Web of Science ®Google Scholar
• Xu C, Yue R, Lv X, Wang S, Du M. 2022. Efficacy and safety of pharmacological interventions for pruritus in primary biliary cholangitis: A systematic review and meta-analysis. Front Pharmacol. 13:835991. doi: 10.3389/fphar.2022.835991.
   PubMed Web of Science ®Google Scholar
• Xue Y, Moore LB, Orans J, Peng L, Bencharit S, Kliewer SA, Redinbo MR. 2007. Crystal structure of the pregnane X receptor-estradiol complex provides insights into endobiotic recognition. Mol Endocrinol. 21(5):1028–1038. doi: 10.1210/me.2006-0323.
   PubMedGoogle Scholar
• Yan J, Xie W. 2016. A brief history of the discovery of PXR and CAR as xenobiotic receptors. Acta Pharm Sin B. 6(5):450–452. doi: 10.1016/j.apsb.2016.06.011.
   PubMed Web of Science ®Google Scholar
• Ye N, Wang H, Hong J, Zhang T, Lin C, Meng C. 2016. PXR mediated protection against liver inflammation by ginkgolide A in tetrachloromethane treated mice. Biomol Ther (Seoul). 24(1):40–48. doi: 10.4062/biomolther.2015.077.
   PubMed Web of Science ®Google Scholar
• Yin J, Li D, Hu W, Meng Q. 2008. Effects of glycyrrhizic acid on cocklebur-induced hepatotoxicity in rat and human hepatocytes. Phytother Res. 22(3):395–400. doi: 10.1002/ptr.2336.
   PubMed Web of Science ®Google Scholar
• Yokoda RT, Rodriguez EA. 2020. Review: pathogenesis of cholestatic liver diseases. World J Hepatol. 12(8):423–435. doi: 10.4254/wjh.v12.i8.423.
   PubMed Web of Science ®Google Scholar
• Yoshinari K. 2019. Role of nuclear receptors PXR and CAR in xenobiotic-induced hepatocyte proliferation and chemical carcinogenesis. Biol Pharm Bull. 42(8):1243–1252. doi: 10.1248/bpb.b19-00267.
   PubMed Web of Science ®Google Scholar
• Yu C, Ye S, Sun H, Liu Y, Gao L, Shen C, Chen S, Zeng S. 2009. PXR-mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIA. Chem Biol Interact. 177(1):58–64. doi: 10.1016/j.cbi.2008.08.013.
   PubMed Web of Science ®Google Scholar
• Zeng H, Jiang Y, Chen P, Fan X, Li D, Liu A, Ma X, Xie W, Liu P, Gonzalez FJ, et al. 2017. Schisandrol B protects against cholestatic liver injury through pregnane X receptors. Br J Pharmacol. 174(8):672–688. doi: 10.1111/bph.13729.
   PubMed Web of Science ®Google Scholar
• Zeng H, Li D, Qin X, Chen P, Tan H, Zeng X, Li X, Fan X, Jiang Y, Zhou Y, et al. 2016. Hepatoprotective effects of Schisandra sphenanthera extract against lithocholic acid-induced cholestasis in male mice are associated with activation of the pregnane X receptor pathway and promotion of liver regeneration. Drug Metab Dispos. 44(3):337–342. doi: 10.1124/dmd.115.066969.
   PubMed Web of Science ®Google Scholar
• Zhang DK, Cheng LN, Huang XL, Shi W, Xiang JY, Gan HT. 2009. Tetrandrine ameliorates dextran-sulfate-sodium-induced colitis in mice through inhibition of nuclear factor -kappaB activation. Int J Colorectal Dis. 24(1):5–12. doi: 10.1007/s00384-008-0544-7.
   PubMed Web of Science ®Google Scholar
• Zhang RX, Dong K, Wang Z, Miao R, Lu W, Wu XY. 2021. Nanoparticulate drug delivery strategies to address intestinal cytochrome P450 CYP3A4 metabolism towards personalized medicine. Pharmaceutics. 13(8):1261. doi: 10.3390/pharmaceutics13081261.
   Web of Science ®Google Scholar
• Zhang G, Liu M, Song M, Wang J, Cai J, Lin C, Li Y, Jin X, Shen C, Chen Z, et al. 2020. Patchouli alcohol activates PXR and suppresses the NF-kappaB-mediated intestinal inflammatory. J Ethnopharmacol. 248:112302. doi: 10.1016/j.jep.2019.112302.
   PubMed Web of Science ®Google Scholar
• Zhang X, Ma Z, Liang Q, Tang X, Hu D, Liu C, Tan H, Xiao C, Zhang B, Wang Y, et al. 2015. Tanshinone IIA exerts protective effects in a LCA-induced cholestatic liver model associated with participation of pregnane X receptor. J Ethnopharmacol. 164:357–367. doi: 10.1016/j.jep.2015.01.047.
   PubMed Web of Science ®Google Scholar
• Zhou C, Tabb MM, Nelson EL, Grun F, Verma S, Sadatrafiei A, Lin M, Mallick S, Forman BM, Thummel KE, et al. 2006. Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. J Clin Invest. 116(8):2280–2289. doi: 10.1172/JCI26283.
   PubMed Web of Science ®Google Scholar
• Zollner G, Marschall HU, Wagner M, Trauner M. 2006. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm. 3(3):231–251. doi: 10.1021/mp060010s.
   PubMedGoogle Scholar